Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4 + T cells, which promote their expansion

Ramin Radpour, Cedric Simillion, Bofei Wang, Hussein A. Abbas, Carsten Riether, Adrian F. Ochsenbein

Blood (2024) 144 (8): 888–903.

https://doi.org/10.1182/blood.2024024000

Published: 2024

Includes: Supplemental data

Journal Articles

Targeting CD70 with Cusatuzumab Eliminates Acute Myeloid Leukemia Stem Cells in Humans

Blood (2019) 134 (Supplement_1): 234.

https://doi.org/10.1182/blood-2019-129916

Published: 2019

Journal Articles

CD93-Signaling Regulates Self-Renewal and Proliferation of Chronic Myeloid Leukemia Stem Cells in Mice and Humans and Might be a Promising Target for Treatment

Carsten Riether, PhD, Ramin Radpour, PhD, Chantal L. Bachmann, MSc, Christian M Schürch, MD PhD, Miroslav Arambasic, PhD, Gabriela M Baerlocher, MD, Adrian F Ochsenbein, MD

Blood (2019) 134 (Supplement_1): 187.

https://doi.org/10.1182/blood-2019-127864

Published: 2019

Journal Articles

The Combination of the BCL-2 Antagonist Venetoclax with the CD70-Targeting Antibody Cusatuzumab Synergistically Eliminates Primary Human Leukemia Stem Cells

Carsten Riether, PhD, Tanja Chiorazzo, PhD, Amy J. Johnson, PhD, Christina Diane Drenberg, PhD, Khaja Waheeduddin Syed, BPharm, MS, Mahan Moshir, MSc, Anna Hultberg, PhD, Nicolas Leupin, Hans De Haard, Adrian F Ochsenbein, MD

Blood (2019) 134 (Supplement_1): 3918.

https://doi.org/10.1182/blood-2019-127464

Published: 2019

Journal Articles

Splenic CD24 low Red Pulp Macrophages Provide an Alternate Niche for Chronic Myeloid Leukemia Stem Cells

Michael A Amrein, MD PhD, Elias D Bührer, MD PhD, Stefan Forster, MD, Stephan Isringhausen, Christian M Schürch, MD PhD, Salil S. Bhate, MMath, Mohamad Al Sayed, PhD, Cesar Nombela Arrieta, PhD, Ramin Radpour, PhD, Carsten Riether, PhD, Adrian F Ochsenbein, MD

Blood (2019) 134 (Supplement_1): 1634.

https://doi.org/10.1182/blood-2019-126593

Published: 2019

Journal Articles

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

Adrian F Ochsenbein, MD, Carsten Riether, PhD, Ulrike Bacher, Rouven Müller, MD, Sabine Höpner, PhD, Yara Banz, Magdalena Hinterbrandner, Msc, Mario Bargetzi, MD, Markus G. Manz, MD, Luc Van Rompaey, PhD, Mahan Moshir, MSc, Tim Delahaye, MSc, Domenica Gandini, MD PhD, Ellen Erzeel, Anna Hultberg, PhD, Samson Fung, MD, Hans De Haard, PhD, Nicolas Leupin, MD, Thomas Pabst, MD PhD

Blood (2018) 132 (Supplement 1): 2680.

https://doi.org/10.1182/blood-2018-99-118302

Published: 2018

Journal Articles

The Traf2 and Nck-Interacting Kinase Is a Conserved Regulator of Self-Renewal in Hematopoietic and Leukemia Stem Cells

Michael A Amrein, MD, Elias D Bührer, MD, Carla Ruckstuhl, PhD, Sabine Höpner, PhD, Carsten Riether, PhD, Adrian F Ochsenbein, MD

Blood (2017) 130 (Supplement 1): 1137.

https://doi.org/10.1182/blood.V130.Suppl_1.1137.1137

Published: 2017

Journal Articles

Blocking CD70/CD27 Signaling in Combination with Hypomethylating Agents Eradicates Human CD34 + AML Stem and Progenitor Cells in Vitro and In Vivo

Magdalena Hinterbrandner, Msc, Nils Maria Kallen, Ursina Lüthi, Thomas Pabst, MD, Luc Van Rompaey, PhD, Nicolas Leupin, MD, Hans De Haard, PhD, Adrian F Ochsenbein, MD, Carsten Riether, PhD

Blood (2017) 130 (Supplement 1): 2652.

https://doi.org/10.1182/blood.V130.Suppl_1.2652.2652

Published: 2017

Journal Articles

Splenic Red Pulp Macrophages Provide a Secondary Stem Cell Niche for Chronic Myeloid Leukemia Stem Cells

Elias D Bührer, MD, Michael A Amrein, MD, Stephan Isringhausen, Cesar Nombela-Arrieta, Carsten Riether, PhD, Adrian F Ochsenbein, MD

Blood (2017) 130 (Supplement 1): 2861.

https://doi.org/10.1182/blood.V130.Suppl_1.2861.2861

Published: 2017

Journal Articles

CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies

Mohamad F. Al Sayed, Carla A. Ruckstuhl, Tamara Hilmenyuk, Christina Claus, Jean-Pierre Bourquin, Beat C. Bornhauser, Ramin Radpour, Carsten Riether, Adrian F. Ochsenbein

Blood (2017) 130 (3): 297–309.

https://doi.org/10.1182/blood-2016-12-756585

Published: 2017

Includes: Supplemental data

Journal Articles

CD70/CD27 Signaling Mediates Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors By Compensatory Activation of the Wnt Pathway

Carsten Riether, PhD, Christian M. Schürch, MD PhD, Ramin Radpour, PhD, Magdalena Hinterbrandner, Anne-Laure Huguenin, Adrian F. Ochsenbein, Prof. MD

Blood (2014) 124 (21): 400.

https://doi.org/10.1182/blood.V124.21.400.400

Published: 2014

Journal Articles

Programmed death 1 signaling on chronic myeloid leukemia–specific T cells results in T-cell exhaustion and disease progression

Sabine Mumprecht, Christian Schürch, Juerg Schwaller, Max Solenthaler, Adrian F. Ochsenbein

Blood (2009) 114 (8): 1528–1536.

https://doi.org/10.1182/blood-2008-09-179697

Published: 2009

Journal Articles

Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells

Sabine Mumprecht, Christina Claus, Christian Schürch, Viktor Pavelic, Matthias S. Matter, Adrian F. Ochsenbein

Blood (2009) 113 (19): 4681–4689.

https://doi.org/10.1182/blood-2008-05-156471

Published: 2009

Journal Articles

PD-1 Signaling on Chronic Myeloid Leukemia-Specific T Cells Results in T Cell Exhaustion and Disease Progression.

Sabine Mumprecht, PhD, Juerg Schwaller, Max Solenthaler, Adrian F. Ochsenbein

Blood (2007) 110 (11): 2923.

https://doi.org/10.1182/blood.V110.11.2923.2923

Published: 2007

Journal Articles

Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections

Sabine Mumprecht, Matthias Matter, Viktor Pavelic, Adrian F. Ochsenbein

Blood (2006) 108 (10): 3406–3413.

https://doi.org/10.1182/blood-2006-04-018705

Published: 2006

NARROW

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4 + T cells, which promote their expansion

Targeting CD70 with Cusatuzumab Eliminates Acute Myeloid Leukemia Stem Cells in Humans

CD93-Signaling Regulates Self-Renewal and Proliferation of Chronic Myeloid Leukemia Stem Cells in Mice and Humans and Might be a Promising Target for Treatment

The Combination of the BCL-2 Antagonist Venetoclax with the CD70-Targeting Antibody Cusatuzumab Synergistically Eliminates Primary Human Leukemia Stem Cells

Splenic CD24 low Red Pulp Macrophages Provide an Alternate Niche for Chronic Myeloid Leukemia Stem Cells

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

The Traf2 and Nck-Interacting Kinase Is a Conserved Regulator of Self-Renewal in Hematopoietic and Leukemia Stem Cells

Blocking CD70/CD27 Signaling in Combination with Hypomethylating Agents Eradicates Human CD34 + AML Stem and Progenitor Cells in Vitro and In Vivo

Splenic Red Pulp Macrophages Provide a Secondary Stem Cell Niche for Chronic Myeloid Leukemia Stem Cells

CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies

CD70/CD27 Signaling Mediates Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors By Compensatory Activation of the Wnt Pathway

Programmed death 1 signaling on chronic myeloid leukemia–specific T cells results in T-cell exhaustion and disease progression

Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells

PD-1 Signaling on Chronic Myeloid Leukemia-Specific T Cells Results in T Cell Exhaustion and Disease Progression.

Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only